Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results

Go back to Calidi Biotherapeutics Reports Third Quarter 2023 Operating and Financial Results
(NYSE: CLDI) Delayed: 1.36 -0.23 (14.47%)
Previous Close $1.59    52 Week High
Open $1.58    52 Week Low
Day High $1.58    P/E N/A 
Day Low $1.33    EPS
Volume 295,380